Source: Registered Drug Product Database (NG) Revision Year: 2025 Publisher: Unique Pharmaceuticals Limited, 11, Fatai Atere Way, Matori-Mushin Lagos, Tel: +234 8097421000, Email: mail@uniquepharm.com Drug product manufacturer: Unique Pharmaceuticals Limited, Km 38, Abeokuta Road, Sango-Ota, Ogun State, Nigeria, Tel: +234 8097421000, Email: mail@uniquepharm.com
UNIGYL SUSPENSION (Metronidazole BP 200 mg/5 ml suspension).
Strength:
Each 5 ml contains:
Metronidazole benzoate equivalent to metronidazole B.P 200 mg.
Pharmaceutical/Dosage form:
Suspension.
| Pharmaceutical Form |
|---|
|
Suspension. A clear yellow-coloured viscous aqueous suspension. |
Each 5 ml contains:
Metronidazole benzoate equivalent to metronidazole B.P 200 mg.
Excipients:
For the full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
Metronidazole is an anti-infectious drug belonging to the pharmacotherapeutic group of nitroimidazole derivatives, which have effect mainly on strict anaerobes. This effect is probably caused by interaction with DNS and different metabolites. |
| List of Excipients | |||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
60 ml amber PET bottle with tamper evident ROPP cap.
Unique Pharmaceuticals Limited, 11, Fatai Atere Way, Matori-Mushin Lagos, Tel: +234 8097421000, Email: mail@uniquepharm.com
Drug product manufacturer: Unique Pharmaceuticals Limited, Km 38, Abeokuta Road, Sango-Ota, Ogun State, Nigeria, Tel: +234 8097421000, Email: mail@uniquepharm.com
04-4987
| Drug | Countries | |
|---|---|---|
| UNIGYL | Nigeria |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.